Physician profile
Valeria C Cohran
NPI 1972611234
$211,981.36
in general payments reported to CMS, 2019-2025
7 companies · $76K in 2025
The $76K reported for 2025 was more than what 99% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $8,520 · 2021: $1,272 · 2022: $39K · 2023: $32K · 2024: $44K · 2025: $76K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $69K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $54K · Travel and Lodging: $17K · Consulting Fee: $6,020 · Food and Beverage: $3,022 · Education: $3,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $68,681.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,374.50 |
| Travel and Lodging | $16,726.65 |
| Consulting Fee | $6,020.00 |
| Food and Beverage | $3,021.75 |
| Education | $3,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $114,726.51 | 2019-2025 | Gattex |
| Alcresta Therapeutics, INC. | $84,852.71 | 2019-2025 | Relizorb |
| Shire North American Group INC | $8,531.37 | 2019 | |
| Baxter Healthcare | $3,015.49 | 2024-2025 | Fluid Systems - Infusion Systems |
| Eli Lilly and Company | $625.00 | 2025 | Omvoh |
| Incyte Corporation | $129.19 | 2021 | |
| Fresenius Kabi USA, LLC | $101.09 | 2023-2025 | Smoflipid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Valeria Cohran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.